TetraLogic Pharmaceuticals to Present Data From Its SMAC-Mimetic Program at Upcoming AACR Annual Meeting 2014
27. März 2014 16:05 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., March 27, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that data from its novel SMAC-Mimetic program will be presented during...
J. Kevin Buchi, President and Chief Executive Officer, Awarded the Pennsylvania Bio's Frank Baldino Bioscience CEO of the Year
13. März 2014 07:30 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., March 13, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that J. Kevin Buchi, President and Chief Executive Officer, is the recipient of...
TetraLogic to Present at the Cowen and Company 34th Annual Health Care Conference
26. Februar 2014 07:30 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Feb. 26, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that J. Kevin Buchi, President and Chief Executive Officer, will present at the...
TetraLogic Announces Licensing and Research Collaboration With Walter and Eliza Hall Institute of Medical Research
21. Januar 2014 07:30 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Jan. 21, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has entered into a research collaboration with the Walter and Eliza Hall...
TetraLogic Announces Exercise of Over-Allotment Option
31. Dezember 2013 16:05 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Dec. 31, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that the underwriters for its initial public offering of common stock have...
TetraLogic Announces Closing of Initial Public Offering of Common Stock
17. Dezember 2013 16:05 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Dec. 17, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced the closing of its initial public offering of 7,150,000 shares of its common stock...
TetraLogic Announces Pricing of Initial Public Offering of Common Stock
12. Dezember 2013 07:30 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Dec. 12, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (TetraLogic) today announced pricing of its initial public offering of 7,150,000 shares of its common stock at a...